股票 › NBIX
神经分泌生物科学 NBIX
美股市值排名 #1052
$164.63 +$4.87 (+3.05%)
休市 · Nov 6, 10:00 pm ET · 最新盘后价 $164.63 0.00%
开盘$159.98
昨收$159.76
当日区间$158.66 – $165.86
成交量1.51M
市值$16.66B
市盈率（TTM）24.4
股息率–
NBIX 相关新闻
匹配 Neurocrine Biosciences 或代码 NBIX 的头条新闻，按最新排序。
- Citi Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Maintains Target Price $253
- Citi Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Raises Target Price to $253 正面
- UBS Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Cuts Target Price to $214 负面
- Bernstein Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Maintains Target Price $218
- Neurocrine (NBIX) Receives a Buy From CCB Intl.
- RBC Capital Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Maintains Target Price $198
- Morgan Stanley Maintains Neurocrine Biosciences(NBIX.US) With Hold Rating, Raises Target Price to $183 正面
- J.P. Morgan Reaffirms Their Buy Rating on Neurocrine (NBIX)
- J.P. Morgan Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Announces Target Price $217
- A Quick Look at Today's Ratings for Neurocrine Biosciences(NBIX.US), With a Forecast Between $194 to $249
- CCORF Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Raises Target Price to $210 正面
- Citi Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Maintains Target Price $249
- Morgan Stanley Maintains Neurocrine Biosciences(NBIX.US) With Hold Rating, Maintains Target Price $182
- BMO Capital Maintains Neurocrine Biosciences(NBIX.US) With Hold Rating, Maintains Target Price $190
- Evercore Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Raises Target Price to $215 正面
暂无评论——快来第一个聊聊 NBIX。
登录后参与讨论。